Gastrointestinal side effects such as nausea, vomiting, and diarrhoea can cause dehydration leading to increased thirst
Retatrutide is a glucagon-like peptide-1, or GLP-1 receptor agonist, that like the other popular weight loss drugs is also meant to treat diabetes
The current body of literature is predominantly composed of observational studies and basic research, which, while informative, do not provide the robust evidence required to shift clinical practice guidelines
The Skin Institute meets all these safety standards
These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist with a slightly different mechanism
The honest answer is: for most people, yes, at least some weight is likely to return after stopping